The use of Cytoarray (array CGH) is prescribed for patients with a normal karyotype but clinical profile compatible with a chromosomal disorder.
Range of flexible NGS tests for exome sequencing and exome-based panels.
Non invasive, hight sensitivity test for detection of cell-free circulating tumor DNA (ctDNA) in the patient's bloodstream
The trisomies of chromosomes 13 (Patau syndrome), 18 (Edwards syndrome) and 21 (Down syndrome) are produced by an extra copy of chromosomes 13, 18 and 21 respectively. All of them are relatively frequent trisomies and highly compatible with a practically normal development of the foetus.
Our mission is providing fast molecular diagnosis of genetic diseases, in early stages when possible, turning analytical results into useful and actionable information for physicians and patients..
Our commitment with the medical community is an accurate diagnosis for the best therapeutic chances and suitable genetic counseling of every patient.About Bioarray >
Browse our test catalogue.
Next Generation Sequencing, Microarrays, Deletion/Duplication Testing, Repeat Expansion Analysis, etc.Look for tests >
Prenatal Diagnosis Applying Array CGH (molecular karyotype) in prenatal diagnosis is especially recommended in cases of polymalformed foetuses....
Early genetic diagnosis of trisomy foetuses. The trisomies of chromosomes 13 (Patau syndrome), 18 (Edwards syndrome) and 21 (Down syndrome)...
Most comprehensive NGS Panel for Epilepsy covering 543 genes.